Loading…

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications at different stages of diagnosis, and for staging and follow-up. This review first considers...

Full description

Saved in:
Bibliographic Details
Published in:European Journal of Nuclear Medicine 1996-12, Vol.23 (12), p.1641-1674
Main Authors: RIGO, P, PAULUS, P, KASCHTEN, B. J, HUSTINX, R, BURY, T, JERUSALEM, G, BENOIT, T, FOIDART-WILLEMS, J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications at different stages of diagnosis, and for staging and follow-up. This review first considers the biological characteristics of FDG and then discusses methodological considerations regarding its use. Clinical indications are considered, and the results achieved in respect of various organs and tumour types are reviewed in depth. The review concludes with a brief consideration of the ways in which clinical PET might be improved.
ISSN:0340-6997
1432-105X
1619-7089
DOI:10.1007/bf01249629